Show simple item record

Deciduoid mesothelioma: Cytologic presentation and diagnostic pitfalls

dc.contributor.authorHuang, Cheng Chengen_US
dc.contributor.authorMichael, Claire W.en_US
dc.date.accessioned2013-07-08T17:45:19Z
dc.date.available2014-09-02T14:12:52Zen_US
dc.date.issued2013-07en_US
dc.identifier.citationHuang, Cheng Cheng; Michael, Claire W. (2013). "Deciduoid mesothelioma: Cytologic presentation and diagnostic pitfalls." Diagnostic Cytopathology 41(7): 629-635. <http://hdl.handle.net/2027.42/98759>en_US
dc.identifier.issn8755-1039en_US
dc.identifier.issn1097-0339en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/98759
dc.description.abstractWe report two cases of malignant deciduoid mesothelioma (MDM), a very rare variant of malignant mesothelioma (MM). Case 1: An 18‐year‐old male with no history of asbestos exposure presented with worsening abdominal pain, anorexia, and vomiting after a motor vehicle accident. A CT scan showed small amount of ascites and abdominal mass. An exploratory laparotomy revealed multiple yellow tan, firm nodules on the peritoneum and omentum. He received palliative treatment and died 5 months after the diagnosis. Case 2: A 64‐year‐old female with history of asbestos exposure initially presented with abdominal distension. CT scan showed abdominal mass with a large amount of ascites. A diagnostic laparoscopy revealed multiple peritoneal nodules. She underwent several regimens of chemotherapy over a period of 69 months and is still alive to date. In both cases, features of mesothelial origin were subtle and the smears showed predominantly single cells with marked nuclear atypia. The second case also contained few two‐dimensional loose cell clusters with scalloped or hobnail borders. The clusters often exhibited a pseudoacinar structure surrounding a globular extracellular material. Groups of three to four cells often formed doublets and triplets with cell‐to‐cell windows. Our results show that MDM may not present with the traditional cytological features described in MM and can manifest with more nuclear pleomorphism resulting in erroneous diagnosis. Recognition of the subtle mesothelial features along with the appropriate ancillary tests is essential for accurate diagnosis. Diagn. Cytopathol. 2013. © 2012 Wiley Periodicals, Inc.en_US
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherPeritoneal Effusionen_US
dc.subject.otherCytologyen_US
dc.subject.otherMalignant Deciduoid Mesotheliomaen_US
dc.titleDeciduoid mesothelioma: Cytologic presentation and diagnostic pitfallsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPathologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherDepartment of Pathology, Case Western Reserve University/University Hospitals Case Medical Center, 11100 Euclid Ave Rm 212B, Cleveland, OH 44106, USAen_US
dc.identifier.pmid23008275en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/98759/1/22902_ftp.pdf
dc.identifier.doi10.1002/dc.22902en_US
dc.identifier.sourceDiagnostic Cytopathologyen_US
dc.identifier.citedreferenceGoodman JE, Nascarella MA, Valberg PA. Ionizing radiation: a risk factor for mesothelioma. Cancer Causes Control 2009; 20: 1237 – 1254.en_US
dc.identifier.citedreferenceShanks JH, Harris M, Banerjee SS, et al. Mesotheliomas withdeciduoid morphology: A morphologic spectrum and a variantnot confined to young females. Am J Surg Pathol 2000; 24: 285 – 294.en_US
dc.identifier.citedreferenceNascimento AG, Keeney GL, Fletcher CD. 1994. Deciduoid peritoneal mesothelioma. An unusual phenotype affecting young females. Am J Surg Pathol 1994; 18: 439 – 445.en_US
dc.identifier.citedreferenceSerio G, Scattone A, Pennella A, et al. Malignant deciduoid mesothelioma of the pleura: Report of two cases with long survival. Histopathology 2002; 40: 348 – 352.en_US
dc.identifier.citedreferenceGillespie FR, van der Walt JD, Derias N, Kenney A. Deciduoid peritoneal mesothelioma. A report of the cytological appearances. Cytopathology 2001; 12: 57 – 61.en_US
dc.identifier.citedreferenceReis‐Filho JS, Pope LZ, Milanezi F, Balderrama CM, Serapiao MJ, Schmitt FC. Primary epithelial malignant mesothelioma of the pericardium with deciduoid features: Cytohistologic and immunohistochemical study. Diagn Cytopathol 2002; 26: 117 – 122.en_US
dc.identifier.citedreferenceRussell HK, Jr. A modification of Movat's pentachrome stain. Arch Pathol 1972; 94: 187 – 191.en_US
dc.identifier.citedreferenceHasteh F, Lin GY, Weidner N, Michael CW. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol 2010; 118: 90 – 96.en_US
dc.identifier.citedreferenceCugell DW, Kamp DW. Asbestos and the pleura: A review. Chest 2004; 125: 1103 – 1117.en_US
dc.identifier.citedreferenceBridda A, Padoan I, Mencarelli R, Frego M. 2007. Peritoneal mesothelioma: A review. MedGenMed 2007; 9: 32.en_US
dc.identifier.citedreferenceAntman KH, Pomfret EA, Aisner J, MacIntyre J, Osteen RT, Greenberger JS. Peritoneal mesothelioma: Natural history and response to chemotherapy. J Clin Oncol 1983; 1: 386 – 391.en_US
dc.identifier.citedreferenceMetz‐Flamant C, Guseva Canu I, Laurier D. Malignant pleural mesothelioma risk among nuclear workers: A review. J Radiol Prot 2011; 31: 9 – 23.en_US
dc.identifier.citedreferenceIsmail‐Khan R, Robinson LA, Williams CC, Jr, Garrett CR, Bepler G, Simon GR. Malignant pleural mesothelioma: A comprehensive review. Cancer Control 2006; 13: 255 – 263.en_US
dc.identifier.citedreferenceVogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21: 2636 – 2644.en_US
dc.identifier.citedreferenceMirarabshahii P, Pillai K, Chua TC, Pourgholami MH, Morris DL. Diffuse malignant peritoneal mesothelioma—An update on treatment. Cancer Treat Rev 2011; 38: 605 – 612.en_US
dc.identifier.citedreferenceKleinberg L, Lie AK, Florenes VA, Nesland JM, Davidson B. Expression of inhibitor‐of‐apoptosis protein family members in malignant mesothelioma. Hum Pathol 2007; 38: 986 – 994.en_US
dc.identifier.citedreferenceGranados R, Cibas ES, Fletcher JA. Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology. Acta Cytol 1994; 38: 711 – 717.en_US
dc.identifier.citedreferenceXiao S, Renshaw A, Cibas ES, Hudson TJ, Fletcher JA. Novel fluorescence in situ hybridization approaches in solid tumors. Characterization of frozen specimens, touch preparations, and cytological preparations. Am J Pathol 1995; 147: 896 – 904.en_US
dc.identifier.citedreferencePu RT, Pang Y, Michael CW. Utility of WT‐1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions. Diagn Cytopathol 2008; 36: 20 – 25.en_US
dc.identifier.citedreferenceLozano MD, Panizo A, Toledo GR, Sola JJ, Pardo‐Mindan J. Immunocytochemistry in the differential diagnosis of serous effusions: A comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears. Cancer 2001; 93: 68 – 72.en_US
dc.identifier.citedreferenceWiseman W, Michael CW, Roh MH. Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic Mullerian carcinoma in effusions. Diagn Cytopathol 2011; 39: 651 – 656.en_US
dc.identifier.citedreferenceSantos C, Gamboa F, Fradinho F, Pego A, Carvalho L, Bernardo J. Deciduoid pleural mesothelioma—A rare entity in a young woman. Rev Port Pneumol 2012 Mar 15. [Epub ahead of print].en_US
dc.identifier.citedreferenceOkonkwo A, Musunuri S, Diaz L, Jr, Bedrossian C, Stryker S, Rao S. Deciduoid mesothelioma: A rare, distinct entity with unusual features. Ann Diagn Pathol 2001; 5: 168 – 171.en_US
dc.identifier.citedreferenceMourra N, de Chaisemartin C, Goubin‐Versini I, Parc R, Flejou JF. Malignant deciduoid mesothelioma: A diagnostic challenge. Arch Pathol Lab Med 2005; 129: 403 – 406.en_US
dc.identifier.citedreferenceMichael CW. Maligant mesothelioma. In: Davidson B, Pinar F, Michael CW, editors. Serous effusions. London: Springer; 2012. p 79 – 98.en_US
dc.identifier.citedreferenceTalerman A. Deciduoid or pseudodecidual mesothelioma. Am J Surg Pathol 2000; 24: 1179.en_US
dc.identifier.citedreferenceKato Y, Tsuta K, Seki K, et al. Immunohistochemical detection of GLUT‐1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol 2007; 20: 215 – 220.en_US
dc.identifier.citedreferenceWu M, Sun Y, Li G, et al. Immunohistochemical detection of XIAP in mesothelium and mesothelial lesions. Am J Clin Pathol 2007; 128: 783 – 787.en_US
dc.identifier.citedreferenceUstun H, Astarci HM, Sungu N, Ozdemir A, Ekinci C. Primary malignant deciduoid peritoneal mesothelioma: A report of the cytohistological and immunohistochemical appearances. Diagn Cytopathol 2011; 39: 402 – 408.en_US
dc.identifier.citedreferenceTalerman A, Montero JR, Chilcote RR, Okagaki T. Diffuse malignant peritoneal mesothelioma in a 13‐year‐old girl. Report of a case and review of the literature. Am J Surg Pathol 1985; 9: 73 – 80.en_US
dc.identifier.citedreferenceOrdonez NG. Epithelial mesothelioma with deciduoid features: Report of four cases. Am J Surg Pathol 2000; 24: 816 – 823.en_US
dc.identifier.citedreferenceShia J, Erlandson RA, Klimstra DS. Deciduoid mesothelioma: A report of 5 cases and literature review. Ultrastruct Pathol 2002; 26: 355 – 363.en_US
dc.identifier.citedreferenceHenley JD, Loehrer PJ, Sr, Ulbright TM. Deciduoid mesothelioma of the pleura after radiation therapy for Hodgkin's disease presenting as a mediastinal mass. Am J Surg Pathol 2001; 25: 547 – 548.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.